| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/27/2013 | CN101137623B N-sulphonylpyrroles and use thereof as histone deacetylase inhibitors |
| 03/27/2013 | CN101072503B 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides |
| 03/26/2013 | US8404856 Non-nucleoside reverse transcriptase inhibitors |
| 03/26/2013 | US8404852 Gyrase inhibitors and uses thereof |
| 03/26/2013 | US8404765 Sterically hindered amines and use thereof as polymer stabilizers |
| 03/26/2013 | US8404728 Small-molecule botulinum toxin inhibitors |
| 03/26/2013 | US8404690 Piperazine-2-carboxamide derivatives |
| 03/26/2013 | US8404685 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors |
| 03/26/2013 | US8404683 Inhibitors of the interaction between MDM2 and P53 |
| 03/26/2013 | US8404679 Pyrrolidine derivatives as NK2 receptor antagonists |
| 03/21/2013 | WO2013040044A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
| 03/21/2013 | WO2013040013A2 Bimetallic catalysts for co2 hydrogenation and h2 generation from formic acid and/or salts thereof |
| 03/21/2013 | WO2013039140A1 Fused heterocyclic derivative |
| 03/21/2013 | WO2013038944A1 Light-emitting element material and light-emitting element |
| 03/21/2013 | WO2013037957A1 Method for purifying contrast media |
| 03/21/2013 | WO2013037753A1 Plant growth regulating compounds |
| 03/21/2013 | WO2013037289A1 Preparation of derivative of 2-methyl-4-amino-5-（substituted-1h-1,2,3-triazol）methyl pyrimidine and microbicidal activity thereof |
| 03/21/2013 | US20130072536 Pyrazole compounds that modulate hsp90 activity |
| 03/21/2013 | US20130072523 Analogues for the treatment or prevention of flavivirus infections |
| 03/21/2013 | US20130072489 Triazole compounds that modulate hsp90 activity |
| 03/21/2013 | US20130072486 Pyrimidine cyclohexyl glucocorticoid receptor modulators |
| 03/21/2013 | US20130072479 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 03/21/2013 | US20130072469 Heteroaryl compounds and uses thereof |
| 03/21/2013 | US20130072468 Substituted piperazines as cb1 antagonists |
| 03/21/2013 | US20130072461 Triazole compounds that modulate hsp90 activity |
| 03/21/2013 | US20130072457 Pyrazolyl quinazoline kinase inhibitors |
| 03/21/2013 | US20130067664 Polyurethane derivatives, composition thereof and dye additives comprising the polyurethane derivatives |
| 03/21/2013 | CA2848226A1 Plant growth regulating compounds |
| 03/21/2013 | CA2844704A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
| 03/20/2013 | EP2570412A1 Novel nitrogen-containing heterocyclic compound and organic electronic device using the same |
| 03/20/2013 | EP2570407A1 Tetrazole-substituted arylamide derivatives and their use as P2x3 and/or P2x2/3 purinergic receptor antagonists |
| 03/20/2013 | EP2569307A2 Lipoic acid and nitroxide derivatives and uses thereof |
| 03/20/2013 | EP2569306A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors |
| 03/20/2013 | EP2569305A1 Substituted n-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569303A1 Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569302A1 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors |
| 03/20/2013 | EP2569301A1 Indazole inhibitors of kinase |
| 03/20/2013 | EP2569300A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors |
| 03/20/2013 | EP2569299A1 Nitrogen- heterocyclic compounds as phosphodiesterase 10 inhibitors |
| 03/20/2013 | EP2569296A1 Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569294A1 Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569289A1 Pyrazines useful as inhibitors of atr kinase |
| 03/20/2013 | EP2569286A2 Compounds useful as inhibitors of atr kinase |
| 03/20/2013 | EP2569280A1 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof |
| 03/20/2013 | CN1606554B Beta-lactamyl vasopressin v1a antagonists |
| 03/20/2013 | CN1302801B Substituted aminoquinazolone (thio-ketone) derivative or its salt, its intermediate and pest controlling agent and its application method |
| 03/20/2013 | CN102985412A 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia |
| 03/20/2013 | CN102985410A Combretastatin analogs for use in the treatment of cancer |
| 03/20/2013 | CN102985405A Heterocyclic compound, and p27 kip1 degradation inhibitor |
| 03/20/2013 | CN102977079A Pyrrodidone compound containing pyrazole group as well as preparation method thereof and application thereof |
| 03/20/2013 | CN102977034A Amino acid base benzimidazole for asymmetric transfer hydrogenation reaction of ketone, and preparation method thereof |
| 03/20/2013 | CN102977032A Heterocyclic bridged biphenyls and their use in OLEDs |
| 03/20/2013 | CN102977029A 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| 03/20/2013 | CN102977016A Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
| 03/20/2013 | CN102977015A Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
| 03/20/2013 | CN102976879A Supported PtAu catalyst and method for catalytic reduction of olefinic bonds or acetylenic bonds by using same |
| 03/20/2013 | CN102351848B Rotenone cyclopropanecarboxamide and its preparation method and use |
| 03/20/2013 | CN101838476B A type of organic fluorescent dye compound and synthesis method and application thereof |
| 03/20/2013 | CN101781287B Irbesartan hydrobromide and preparation method thereof |
| 03/20/2013 | CN101039920B 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |
| 03/19/2013 | US8399668 Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxamides |
| 03/19/2013 | US8399667 4-anilino quinazoline derivatives as antiproliferative agents |
| 03/19/2013 | US8399664 Coloring matter, ink, ink for ink jet, ink jet recording method, color toner, and color filter |
| 03/19/2013 | US8399663 Salt of 1,3,5-triazine-2,4,6-triamine derivative |
| 03/19/2013 | US8399505 Sulfonylpyrroles |
| 03/19/2013 | US8399468 Octahydro-pyrrolo[3,4-B]pyrrole derivatives |
| 03/19/2013 | US8399462 4-[4-(4-benzyloxy-indol-1-yl)-pyrimidin-2-ylamino]-cyclohexanol; autoimmune, inflammatory, metabolic, neurological diseases as well as cancer and pain |
| 03/19/2013 | US8399461 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same |
| 03/19/2013 | US8399454 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 03/19/2013 | US8399450 Compounds and compositions as protein kinase inhibitors |
| 03/19/2013 | US8399448 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis |
| 03/19/2013 | US8399436 N-pyrazolyl carboxamides as CRAC channel inhibitors |
| 03/19/2013 | US8399381 Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same |
| 03/19/2013 | CA2682629C Pyrimidine hydrazide compounds as pgds inhibitors |
| 03/19/2013 | CA2569824C Phthalazine derivatives as parp inhibitors |
| 03/19/2013 | CA2549228C Hiv protease inhibiting compounds |
| 03/14/2013 | WO2013036224A1 Use of 1h-quinazoline- 2, 4 -diones for use in the prevention or treatment photosensitive epilepsy |
| 03/14/2013 | WO2013035826A1 Fused heterocyclic compound |
| 03/14/2013 | WO2013035329A1 Organic electroluminescence element |
| 03/14/2013 | WO2013034506A1 Pde10 modulators |
| 03/14/2013 | WO2013033862A1 4-substituted-(3-substituted-1h-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof |
| 03/14/2013 | WO2013013113A3 Histone deacetylase 6 selective inhibitors for the treatment of bone disease |
| 03/14/2013 | WO2012142029A3 Serms for the treatment of estrogen receptor-mediated disorders |
| 03/14/2013 | WO2010062171A3 Cc-1065 analogs and their conjugates |
| 03/14/2013 | US20130066252 Method for diagnosis for multiple sclerosis involving anti1-receptor antibody |
| 03/14/2013 | US20130066069 Processes for preparing substituted pyrimidines |
| 03/14/2013 | US20130066026 Hardeners for thermosettable resin compositions |
| 03/14/2013 | US20130065925 Pyrrolidin-3-ylacetic acid derivative |
| 03/14/2013 | US20130065919 Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/14/2013 | US20130065905 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine |
| 03/14/2013 | US20130065902 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators |
| 03/14/2013 | US20130065900 Pharmaceutical compounds |
| 03/14/2013 | US20130065896 Fused imidazole derivative |
| 03/14/2013 | US20130065882 VLA-4 inhibitory drug |
| 03/14/2013 | US20130065879 Heteroaryl compounds and uses thereof |
| 03/14/2013 | US20130065842 COMPOUNDS AS RORyT MODULATORS AND USES THEREOF |
| 03/14/2013 | US20130065818 Arylamide Compounds And Compositions And Uses Thereof |
| 03/14/2013 | US20130065325 Zwitterionic reagents |
| 03/14/2013 | US20130064770 Radiolabeled compounds and methods thereof |
| 03/14/2013 | CA2846503A1 Use of 1h-quinazoline-2,4-diones for use in the prevention or treatment of photosensitive epilepsy |